Access in all areas? A round up of developments in market access and health technology assessment: part 9
Open Access
- 1 October 2025
- journal article
- Published by Becaris Publishing Limited in Journal of Comparative Effectiveness Research
- Vol. 14 (10) , e250120
Abstract
In this update, we examine Spain’s comprehensive pharmaceutical legislation reform; France’s refined health economic evaluation approach; and the US’ proposed Most Favored Nation pricing mechanism.Keywords
This publication has 4 references indexed in Scilit:
- Referencing Drug Prices of Other Countries May Not Sustainably Lower Prices in the United States: Lessons From EuropeValue in Health, 2025
- Challenges and reforms in Spain’s health technology assessment system: analysis of criteria influencing medicines’ reimbursement decisions between 2019 and 2022 in SpainThe European Journal of Health Economics, 2025
- Access in all areas? A roundup of developments in market access and health technology assessment: part 6Journal of Comparative Effectiveness Research, 2025
- Valuing the Societal Impact of Medicines and Other Health Technologies: A User Guide to Current Best PracticesForum for Health Economics and Policy, 2024